» Articles » PMID: 11097398

Role of Ultrasonography in the Detection of Intraductal Spread of Breast Cancer: Correlation with Pathologic Findings, Mammography and MR Imaging

Overview
Journal Eur Radiol
Specialty Radiology
Date 2000 Nov 30
PMID 11097398
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to assess the role of US in the detection of intraductal spread of breast cancer in comparison with mammography (MMG) and MRI. In 46 patients with breast cancer, US features of the intraductal component were classified as ductal type or distorted type. Histopathologically, 29 of 46 (63%) cases had intraductal components, and the sensitivity, specificity, and accuracy rates in detection of intraductal spread were 89, 76, and 85%, respectively. Each US pattern demonstrated good correspondence to the histologic components, and the distorted type correlated well with comedo-type carcinoma. Mammography was performed in all cases, and the sensitivity, specificity, and accuracy rates in detection of intraductal spread were 55, 100, and 72%, respectively. In comedo type, MMG could diagnose the extent of intraductal spread more accurately compared with US examination. Magnetic resonance imaging comparison was available in 25 cases. Magnetic resonance imaging depicted intraductal extension as an enhanced area during the early phase of a contrast enhancement study with a sensitivity of 93%. Ultrasound and MRI were closely related in terms of morphologic characteristics: the ductal type of US image correlated well with linear enhancement on MRI, whereas the distorted type correlated with regional or segmental enhancement. Current US examination is useful in depicting the intraductal spread of breast cancer; however, US has a tendency to underestimate intraductal component of comedo type compared with MMG and MRI.

Citing Articles

Virtual monochromatic spectral CT imaging in preoperative evaluations for intraductal spread of breast cancer: comparison with conventional CT and MRI.

Matsuura Y, Kamitani T, Sagiyama K, Yamasaki Y, Hino T, Kubo M Jpn J Radiol. 2023; 41(7):733-740.

PMID: 36729189 PMC: 10313559. DOI: 10.1007/s11604-023-01392-4.


Breast non-mass-like lesions on contrast-enhanced ultrasonography: Feature analysis, breast image reporting and data system classification assessment.

Xu P, Yang M, Liu Y, Li Y, Zhang H, Shao G World J Clin Cases. 2020; 8(4):700-712.

PMID: 32149054 PMC: 7052556. DOI: 10.12998/wjcc.v8.i4.700.


Breast contrast-enhanced ultrasound: is a scoring system feasible? A preliminary study in China.

Xiao X, Ou B, Yang H, Wu H, Luo B PLoS One. 2014; 9(8):e105517.

PMID: 25133534 PMC: 4136879. DOI: 10.1371/journal.pone.0105517.


Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.

Iwasa H, Kubota K, Hamada N, Nogami M, Nishioka A Oncol Rep. 2014; 31(4):1555-60.

PMID: 24535214 PMC: 3975989. DOI: 10.3892/or.2014.3025.


Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer.

Girardi V, Carbognin G, Camera L, Baglio I, Bucci A, Bonetti F Radiol Med. 2011; 116(8):1226-38.

PMID: 21744256 DOI: 10.1007/s11547-011-0704-7.